BIOMAT Database Logo BIOMAT Database Logo

[Embolism prophylaxis in general surgery using small doses of heparin administered subcutaneously]. 1978

L Wijnja, and J G Nysingh, and P Versteeg, and H Zweep

UI MeSH Term Description Entries
D007279 Injections, Subcutaneous Forceful administration under the skin of liquid medication, nutrient, or other fluid through a hollow needle piercing the skin. Subcutaneous Injections,Injection, Subcutaneous,Subcutaneous Injection
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011183 Postoperative Complications Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery. Complication, Postoperative,Complications, Postoperative,Postoperative Complication
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D004617 Embolism Blocking of a blood vessel by an embolus which can be a blood clot or other undissolved material in the blood stream. Embolus,Embolisms
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000367 Age Factors Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time. Age Reporting,Age Factor,Factor, Age,Factors, Age
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

L Wijnja, and J G Nysingh, and P Versteeg, and H Zweep
[Pharmacologic action of "low doses" or "small doses" of heparin administered subcutaneously].
January 1978, La Nouvelle presse medicale,
L Wijnja, and J G Nysingh, and P Versteeg, and H Zweep
[Low doses subcutaneously administered heparin as thrombosis prevention in surgery].
January 1976, Nederlands tijdschrift voor geneeskunde,
L Wijnja, and J G Nysingh, and P Versteeg, and H Zweep
[Prevention of postoperative thromboembolic complications with subcutaneously administered small doses of heparin].
March 1977, Fortschritte der Medizin,
L Wijnja, and J G Nysingh, and P Versteeg, and H Zweep
[Letter: Postoperative thrombosis prevention with low doses of heparin administered subcutaneously].
March 1976, Nederlands tijdschrift voor geneeskunde,
L Wijnja, and J G Nysingh, and P Versteeg, and H Zweep
[Prophylaxis of postoperative venous thrombosis by subcutaneous heparin administered in small doses. Recent findings].
January 1975, Anesthesie, analgesie, reanimation,
L Wijnja, and J G Nysingh, and P Versteeg, and H Zweep
Small heparin doses as prophylaxis against deep-vein thrombosis in major surgery.
January 1975, Acta chirurgica Scandinavica,
L Wijnja, and J G Nysingh, and P Versteeg, and H Zweep
[Prevention of thrombosis with heparin administered subcutaneously].
August 1961, Nordisk medicin,
L Wijnja, and J G Nysingh, and P Versteeg, and H Zweep
[Use of a subcutaneously administered heparin preparation].
April 1974, Die Medizinische Welt,
L Wijnja, and J G Nysingh, and P Versteeg, and H Zweep
[Biochemistry of oxalic acid. IV. Excretion of small subcutaneously administered doses in dogs].
January 1957, Hoppe-Seyler's Zeitschrift fur physiologische Chemie,
L Wijnja, and J G Nysingh, and P Versteeg, and H Zweep
[Prophylaxis of postoperative thrombosis with small doses of heparin].
June 1972, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
Copied contents to your clipboard!